Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)
Status:
RECRUITING
Trial end date:
2029-09-01
Target enrollment:
Participant gender:
Summary
This is an open label, single arm, single-center, pilot study of concurrent phototherapy and POTELIGEO (mogamulizumab-kpkc) in early-stage mycosis fungoides.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute